Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium

Aims In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We sought to find out whether Na+-Ca2+ exchanger in human heart failure is regulated by sympathetic activation. In addition, since Na+-Ca2+-e...

Full description

Saved in:
Bibliographic Details
Published inEuropean heart journal Vol. 23; no. 14; pp. 1118 - 1124
Main Authors Schillinger, W., Schneider, H., Minami, K., Ferrari, R., Hasenfuss, G.
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.07.2002
Subjects
Online AccessGet full text
ISSN0195-668X
1522-9645
DOI10.1053/euhj.2001.3044

Cover

Loading…
Abstract Aims In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We sought to find out whether Na+-Ca2+ exchanger in human heart failure is regulated by sympathetic activation. In addition, since Na+-Ca2+-exchange is electrogenic, we conjectured whether increased expression of Na+-Ca2+ exchanger is associated with an increased incidence of cardiac arrhythmias. Methods and Results Twenty-three patients suffering from end-stage cardiac failure were examined in the hours preceding cardiac transplantation. Plasma levels of norepinephrine, epinephrine, atrial natriuretic peptide, renin activity, aldosterone, tumour necrosis factor (TNF)-α, and TNF-receptors were measured. All parameters were elevated relative to 21 healthy control subjects. As determined by immunoblots, protein levels of the Na+-Ca2+ exchanger were increased by 56% and protein levels of sarcoplasmic reticulum (SR) Ca2+-ATPase were decreased by 20% in left ventricles of the explanted failing hearts. A significant correlation between protein and neurohumoral levels was exclusively found for the Na+-Ca2+ exchanger with norepinephrine (r=0·64;P =0·01). Recent Holter ECGs revealed that patients with sustained or non-sustained ventricular tachycardia (more than three consecutive beats) had significantly higher Na+-Ca2+ exchanger protein and plasma norepinephrine levels than patients with a maximum of two consecutive beats (Na+-Ca2+ exchanger: 109±10 vs 83±7, n=11 each, P<0·05; norepinephrine: 1359±159 vs 656±88pg.ml−1, n=9 each, P<0·001). Conclusions Sympathetic activation may enhance the expression of Na+-Ca2+ exchanger in end-stage heart failure. The data support the hypothesis that increased Na+-Ca2+-exchange could favour malignant ventricular arrhythmias. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
AbstractList In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We sought to find out whether Na+-Ca2+ exchanger in human heart failure is regulated by sympathetic activation. In addition, since Na+-Ca2+-exchange is electrogenic, we conjectured whether increased expression of Na+-Ca2+ exchanger is associated with an increased incidence of cardiac arrhythmias.AIMSIn end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We sought to find out whether Na+-Ca2+ exchanger in human heart failure is regulated by sympathetic activation. In addition, since Na+-Ca2+-exchange is electrogenic, we conjectured whether increased expression of Na+-Ca2+ exchanger is associated with an increased incidence of cardiac arrhythmias.Twenty-three patients suffering from end-stage cardiac failure were examined in the hours preceding cardiac transplantation. Plasma levels of norepinephrine, epinephrine, atrial natriuretic peptide, renin activity, aldosterone, tumour necrosis factor (TNF)-alpha, and TNF-receptors were measured. All parameters were elevated relative to 21 healthy control subjects. As determined by immunoblots, protein levels of the Na+-Ca2+ exchanger were increased by 56% and protein levels of sarcoplasmic reticulum (SR) Ca2+-ATPase were decreased by 20% in left ventricles of the explanted failing hearts. A significant correlation between protein and neurohumoral levels was exclusively found for the Na+-Ca2+ exchanger with norepinephrine (r=0.64; P=0.01). Recent Holter ECGs revealed that patients with sustained or non-sustained ventricular tachycardia (more than three consecutive beats) had significantly higher Na+-Ca2+ exchanger protein and plasma norepinephrine levels than patients with a maximum of two consecutive beats (Na+-Ca2+ exchanger: 109+/-10 vs 83+/-7, n=11 each, P<0.05; norepinephrine: 1359+/-159 vs 656+/-88 pg. ml(-1), n=9 each, P<0.001).METHODS AND RESULTSTwenty-three patients suffering from end-stage cardiac failure were examined in the hours preceding cardiac transplantation. Plasma levels of norepinephrine, epinephrine, atrial natriuretic peptide, renin activity, aldosterone, tumour necrosis factor (TNF)-alpha, and TNF-receptors were measured. All parameters were elevated relative to 21 healthy control subjects. As determined by immunoblots, protein levels of the Na+-Ca2+ exchanger were increased by 56% and protein levels of sarcoplasmic reticulum (SR) Ca2+-ATPase were decreased by 20% in left ventricles of the explanted failing hearts. A significant correlation between protein and neurohumoral levels was exclusively found for the Na+-Ca2+ exchanger with norepinephrine (r=0.64; P=0.01). Recent Holter ECGs revealed that patients with sustained or non-sustained ventricular tachycardia (more than three consecutive beats) had significantly higher Na+-Ca2+ exchanger protein and plasma norepinephrine levels than patients with a maximum of two consecutive beats (Na+-Ca2+ exchanger: 109+/-10 vs 83+/-7, n=11 each, P<0.05; norepinephrine: 1359+/-159 vs 656+/-88 pg. ml(-1), n=9 each, P<0.001).Sympathetic activation may enhance the expression of Na+-Ca2+ exchanger in end-stage heart failure. The data support the hypothesis that increased Na+-Ca2+-exchange could favour malignant ventricular arrhythmias.CONCLUSIONSSympathetic activation may enhance the expression of Na+-Ca2+ exchanger in end-stage heart failure. The data support the hypothesis that increased Na+-Ca2+-exchange could favour malignant ventricular arrhythmias.
In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We sought to find out whether Na+-Ca2+ exchanger in human heart failure is regulated by sympathetic activation. In addition, since Na+-Ca2+-exchange is electrogenic, we conjectured whether increased expression of Na+-Ca2+ exchanger is associated with an increased incidence of cardiac arrhythmias. Twenty-three patients suffering from end-stage cardiac failure were examined in the hours preceding cardiac transplantation. Plasma levels of norepinephrine, epinephrine, atrial natriuretic peptide, renin activity, aldosterone, tumour necrosis factor (TNF)-alpha, and TNF-receptors were measured. All parameters were elevated relative to 21 healthy control subjects. As determined by immunoblots, protein levels of the Na+-Ca2+ exchanger were increased by 56% and protein levels of sarcoplasmic reticulum (SR) Ca2+-ATPase were decreased by 20% in left ventricles of the explanted failing hearts. A significant correlation between protein and neurohumoral levels was exclusively found for the Na+-Ca2+ exchanger with norepinephrine (r=0.64; P=0.01). Recent Holter ECGs revealed that patients with sustained or non-sustained ventricular tachycardia (more than three consecutive beats) had significantly higher Na+-Ca2+ exchanger protein and plasma norepinephrine levels than patients with a maximum of two consecutive beats (Na+-Ca2+ exchanger: 109+/-10 vs 83+/-7, n=11 each, P<0.05; norepinephrine: 1359+/-159 vs 656+/-88 pg. ml(-1), n=9 each, P<0.001). Sympathetic activation may enhance the expression of Na+-Ca2+ exchanger in end-stage heart failure. The data support the hypothesis that increased Na+-Ca2+-exchange could favour malignant ventricular arrhythmias.
Aims In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We sought to find out whether Na+-Ca2+ exchanger in human heart failure is regulated by sympathetic activation. In addition, since Na+-Ca2+-exchange is electrogenic, we conjectured whether increased expression of Na+-Ca2+ exchanger is associated with an increased incidence of cardiac arrhythmias. Methods and Results Twenty-three patients suffering from end-stage cardiac failure were examined in the hours preceding cardiac transplantation. Plasma levels of norepinephrine, epinephrine, atrial natriuretic peptide, renin activity, aldosterone, tumour necrosis factor (TNF)-α, and TNF-receptors were measured. All parameters were elevated relative to 21 healthy control subjects. As determined by immunoblots, protein levels of the Na+-Ca2+ exchanger were increased by 56% and protein levels of sarcoplasmic reticulum (SR) Ca2+-ATPase were decreased by 20% in left ventricles of the explanted failing hearts. A significant correlation between protein and neurohumoral levels was exclusively found for the Na+-Ca2+ exchanger with norepinephrine (r=0·64;P =0·01). Recent Holter ECGs revealed that patients with sustained or non-sustained ventricular tachycardia (more than three consecutive beats) had significantly higher Na+-Ca2+ exchanger protein and plasma norepinephrine levels than patients with a maximum of two consecutive beats (Na+-Ca2+ exchanger: 109±10 vs 83±7, n=11 each, P<0·05; norepinephrine: 1359±159 vs 656±88pg.ml−1, n=9 each, P<0·001). Conclusions Sympathetic activation may enhance the expression of Na+-Ca2+ exchanger in end-stage heart failure. The data support the hypothesis that increased Na+-Ca2+-exchange could favour malignant ventricular arrhythmias. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
Author Minami, K.
Schillinger, W.
Hasenfuss, G.
Ferrari, R.
Schneider, H.
Author_xml – sequence: 1
  givenname: W.
  surname: Schillinger
  fullname: Schillinger, W.
  organization: Zentrum Innere Medizin, Abt. Kardiologie und Pneumologie, Universität Göttingen, Germany
– sequence: 2
  givenname: H.
  surname: Schneider
  fullname: Schneider, H.
  organization: Innere Medizin/Endokrinologie und klinische Chemie, Max-Planck-Institut für Psychiatrie, München, Germany
– sequence: 3
  givenname: K.
  surname: Minami
  fullname: Minami, K.
  organization: Klinik für Thorax- und Kardiovascularchirurgie, Herzzentrum Nordrhein-Westfalen, Bad Oeynhausen, Germany
– sequence: 4
  givenname: R.
  surname: Ferrari
  fullname: Ferrari, R.
  organization: Centro di Fisiopatologia Cardiovascolare, Università di Ferrara, Gussago, Brescia, Italy
– sequence: 5
  givenname: G.
  surname: Hasenfuss
  fullname: Hasenfuss, G.
  organization: Zentrum Innere Medizin, Abt. Kardiologie und Pneumologie, Universität Göttingen, Germany
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13783770$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12090750$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1v1DAURS1U1E5LtyyRN7CpMthxEttLNNAPUQGLtqrYWC-OPeOSOKntoM6_J2EGKiGxsnR17rN07jE68L03CL2mZElJyd6bcfOwzAmhS0aK4gVa0DLPM1kV5QFaECrLrKrE_RE6jvGBECIqWh2iI5oTSXhJFihedUMfEnhtcG9x3HYDpI1JTmPQyf2E5HqPbR_wlGLzNAQT4xxN8Bc4y1aQn02x3oBfm4Cdx8Y3WUywNtiCa51f483YgcfdttcQGjd2r9BLC200p_v3BN2ef7pZXWbXXy-uVh-uM80YTVnFWVNYAazWwjYFs40lUpNcA-GypsLYshZU25xVvCmN5FBLKSRooQ23TcVO0Lvd3SH0j6OJSXUuatO24E0_RsWpqDjJ6QS-2YNj3ZlGDcF1ELbqj6YJeLsHIGpobZh8ufjMMS4Y5zO33HE69DEGY58Roua91LyXmvdS815TofinoF367TyFyd7_a9mu5mIyT38_gfBDTdZ4qS7vv6uPxTdZfL67UZz9AqCoqlw
CitedBy_id crossref_primary_10_1016_j_ejheart_2006_10_014
crossref_primary_10_1152_physrev_00014_2006
crossref_primary_10_1517_13543784_13_6_653
crossref_primary_10_1113_jphysiol_2010_203398
crossref_primary_10_1016_j_ejheart_2007_01_011
crossref_primary_10_1161_01_RES_0000069701_19660_14
crossref_primary_10_1161_JAHA_117_005869
crossref_primary_10_1016_j_jsha_2012_01_004
crossref_primary_10_1152_ajpheart_01304_2004
crossref_primary_10_1007_BF02254368
crossref_primary_10_1161_JAHA_120_016900
crossref_primary_10_1016_j_aquatox_2013_07_014
crossref_primary_10_1161_CIRCULATIONAHA_104_494476
crossref_primary_10_1006_jmcc_2002_2037
crossref_primary_10_1007_s10741_019_09883_1
crossref_primary_10_3390_ijms242015472
crossref_primary_10_1007_s10646_013_1107_4
crossref_primary_10_1016_j_cardfail_2008_07_232
crossref_primary_10_1152_ajpheart_00534_2009
ContentType Journal Article
Copyright 2002 INIST-CNRS
Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
Copyright_xml – notice: 2002 INIST-CNRS
– notice: Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1053/euhj.2001.3044
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1522-9645
EndPage 1124
ExternalDocumentID 12090750
13783770
10_1053_euhj_2001_3044
ark_67375_HXZ_D4P94KVT_7
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
-E4
.2P
.GJ
.I3
.ZR
0R~
18M
1B1
1TH
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAFWJ
AAJKP
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABNGD
ABNHQ
ABNKS
ABOCM
ABPQP
ABPTD
ABQLI
ABQNK
ABVGC
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUKT
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFIYH
AFOFC
AFXAL
AFYAG
AGINJ
AGKEF
AGORE
AGQPQ
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
ASPBG
ATGXG
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BSCLL
BTRTY
BVRKM
C1A
CAG
CDBKE
COF
CS3
CZ4
DAKXR
DIK
DILTD
D~K
E3Z
EBS
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FEDTE
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H5~
HAR
HVGLF
HW0
HZ~
IHE
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
M41
MHKGH
ML0
N4W
N9A
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OWPYF
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
ROL
ROX
ROZ
RPZ
RUSNO
RW1
RXO
SEL
TCURE
TEORI
TJX
UHS
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZGI
ZKX
~91
AAYXX
CITATION
.XZ
08P
29G
AAJQQ
AAPGJ
AAWDT
ABSMQ
ACFRR
ACPQN
ACUTJ
ACVCV
ACZBC
ADGHP
ADMTO
AEHUL
AEKPW
AFFQV
AFSHK
AGKRT
AGMDO
AHGBF
AI.
AJDVS
APJGH
AQDSO
AQKUS
ATTQO
AVNTJ
BCGUY
BZKNY
C45
EIHJH
H13
IQODW
MBLQV
NQ-
NTWIH
OB3
OBFPC
OGROG
OVD
O~Y
QBD
RIG
RNI
RZF
TMA
VH1
6.Y
ABQTQ
ABSAR
ADJQC
ADRIX
AFXEN
CGR
CUY
CVF
ECM
EIF
M49
NPM
7X8
ID FETCH-LOGICAL-c331t-673d4f8a3bc8fd43fdf09c02ca079b18ef5b81cf2367d5e97ab9989ac8ce7fd63
ISSN 0195-668X
IngestDate Fri Jul 11 15:43:02 EDT 2025
Wed Feb 19 02:35:35 EST 2025
Mon Jul 21 09:14:40 EDT 2025
Tue Jul 01 02:47:56 EDT 2025
Thu Apr 24 23:00:29 EDT 2025
Tue Aug 05 16:50:21 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 14
Keywords Human
Heart failure
Calcium ion
Pathogenesis
Heart disease
Sodium ion
Cardiovascular disease
Ion exchanger
Terminal stage
Catecholamine
Sympathetic nervous system
Language English
License CC BY 4.0
Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c331t-673d4f8a3bc8fd43fdf09c02ca079b18ef5b81cf2367d5e97ab9989ac8ce7fd63
Notes ark:/67375/HXZ-D4P94KVT-7
local:0.1930441.1118
istex:499958B751A54780B8443FEAA94B79932BDE2F0B
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/eurheartj/article-pdf/23/14/1118/17885047/1118.pdf
PMID 12090750
PQID 71867021
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_71867021
pubmed_primary_12090750
pascalfrancis_primary_13783770
crossref_primary_10_1053_euhj_2001_3044
crossref_citationtrail_10_1053_euhj_2001_3044
istex_primary_ark_67375_HXZ_D4P94KVT_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2002-07-01
PublicationDateYYYYMMDD 2002-07-01
PublicationDate_xml – month: 07
  year: 2002
  text: 2002-07-01
  day: 01
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle European heart journal
PublicationTitleAlternate Eur Heart J
PublicationYear 2002
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References 12090743 - Eur Heart J. 2002 Jul;23(14):1078-80
References_xml – reference: 12090743 - Eur Heart J. 2002 Jul;23(14):1078-80
SSID ssj0008616
Score 1.8282357
Snippet Aims In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown....
In end-stage heart failure, an alteration in the expression of the Na+-Ca2+ exchanger has been reported. Regulation of its expression is largely unknown. We...
SourceID proquest
pubmed
pascalfrancis
crossref
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1118
SubjectTerms Arrhythmia
Biological and medical sciences
Biological Transport
calcium
Cardiac Catheterization
Cardiology. Vascular system
Case-Control Studies
catecholamines
Catecholamines - analysis
Catecholamines - biosynthesis
Cohort Studies
Electrocardiography, Ambulatory
Female
Heart
heart failure
Heart Failure - diagnosis
Heart Failure - enzymology
Heart Failure - surgery
Heart failure, cardiogenic pulmonary edema, cardiac enlargement
Heart Transplantation
Humans
Male
Medical sciences
Middle Aged
myocardium
Myocardium - enzymology
Na+-Ca2+-exchanger
Preoperative Care
Probability
Reference Values
Severity of Illness Index
Sodium-Potassium-Exchanging ATPase - analysis
Sodium-Potassium-Exchanging ATPase - metabolism
Sympathetic Nervous System - physiology
Title Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium
URI https://api.istex.fr/ark:/67375/HXZ-D4P94KVT-7/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/12090750
https://www.proquest.com/docview/71867021
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZCKyEuiHfDo_iA4BBt2feujyFNSUCJUJRCxGVle20okA1qNlLLL-HnMuN9pmp5XTaR4zirfJ_t8ezMfIQ8A5M2CFyhrcjTnuUrO7UEZ46lGY-ZcoQvFeYOT6bh6Nh_swgWnc7PVtTSJhcH8seleSX_gyq0Aa6YJfsPyNaDQgO8B3zhCgjD9a8wHi-N9YxzE2y-9fkS9YWVKcEqK9myOo5QnZUxr8ZAnILR-MoacBde4KMq_xcLiGSpBSbjJ9XT_MQkqxc6fstz2PaATmXthovefFTGznvt20a_zWCE3oIq3uJDq306HB8WrfXDqsl42p-Mt3yvR8PZrD8bN5GNlYOiCWbNf5f42PZpssAKQ6MwXC_KRRJyRT6_tcTC4hy3tmuwF_1LtwLb6Hmozecv6AVwDjy7KDS5XXP7wl5YRyg6XgRH98i-RnZdOICgNsbrRRM8FIdGVLe-9aocaOC93P7FLXNnF2fuGYbf8jXMQF1Ip1x9tjE2zvwWuVkeTmi_YNpt0lHZHXJ9UoZf3CXrhnB0pWmLcLQhHAUgKLTShnDYecp7SLcerclGTzJak42WZKOGbLQh2z1yfDScD0ZWqdphSc9zcswlSX0dc0_IWKe-p1NtM2m7ktsRE06sdCBiR2osHZgGikVcwJGfcRlLFek09O6TnWyVqT1C08gJQqF4nDLhu9LmmvOQhYrDGRlokHaJVf25iSxL2qOyyrfEhFYEXoJgoNKqkyAYXfKi7v-9KOZyZc_nBqu6Gz_9iiGQUZCMFh-TQ_8d89--nydRl-xvgdmMWxKoS55W6CawcuPjOJ6p1WadRFhLEkzsLnlQgN5817UZmvIP_zT4I3KjmXGPyU5-ulFPwEjOxb7h6y_5y75H
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Importance+of+sympathetic+activation+for+the+expression+of+Na%2B-Ca2%2B+exchanger+in+end-stage+failing+human+myocardium&rft.jtitle=European+heart+journal&rft.au=SCHILLINGER%2C+W&rft.au=SCHNEIDER%2C+H&rft.au=MINAMI%2C+K&rft.au=FERRARI%2C+R&rft.date=2002-07-01&rft.pub=Oxford+University+Press&rft.issn=0195-668X&rft.volume=23&rft.issue=14&rft.spage=1118&rft.epage=1124&rft_id=info:doi/10.1053%2Feuhj.2001.3044&rft.externalDBID=n%2Fa&rft.externalDocID=13783770
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon